A Strategy for Modulation of Enzymes in the Ubiquitin System

Modifying Deubiquitinases Protein ubiquitination is a widespread mechanism for cellular regulation, and new regulators are valuable research tools and may help to generate therapeutic small molecules. Ernst et al. (p. 590, published online 3 January) used known crystal structures to roughly define the interaction domain between a ubiquitin-specific protease and a ubiquitinated substrate and then screened ubiquitin variants with changes in these residues to find variants that acted as potent and specific regulators that could modify ubiquitin pathway regulation in cells. A technique for developing specific and potent enzyme inhibitors is validated on enzymes of the ubiquitin‑proteasome system. The ubiquitin system regulates virtually all aspects of cellular function. We report a method to target the myriad enzymes that govern ubiquitination of protein substrates. We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallography. We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity. Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains. Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymatic steps in the ubiquitin system.

[1]  Q. Dou,et al.  Targeting the ubiquitin–proteasome system for cancer therapy , 2013, Expert opinion on therapeutic targets.

[2]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[3]  D. Durocher,et al.  OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. , 2012, Molecular cell.

[4]  B. Raught,et al.  The SUMO-specific isopeptidase SENP2 associates dynamically with nuclear pore complexes through interactions with karyopherins and the Nup107-160 nucleoporin subcomplex , 2011, Molecular biology of the cell.

[5]  C. Loch,et al.  Role of ubiquitylation and USP8‐dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma membrane KCa3.1 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  Xinna Zhang,et al.  USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1 , 2011, The EMBO journal.

[7]  V. Dixit,et al.  Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. , 2011, Molecular cell.

[8]  Matthew D. Smith,et al.  Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. , 2011, Cancer research.

[9]  J. E. V. van Leeuwen,et al.  ERBB2 is a target for USP8-mediated deubiquitination. , 2011, Cellular signalling.

[10]  R. Klevit,et al.  E2s: structurally economical and functionally replete. , 2011, The Biochemical journal.

[11]  P. Cohen,et al.  Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases? , 2010, Cell.

[12]  N. Donato,et al.  Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. , 2010, Cancer research.

[13]  P. Nash,et al.  Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex* , 2010, The Journal of Biological Chemistry.

[14]  Tony Pawson,et al.  ProHits: an integrated software platform for mass spectrometry-based interaction proteomics , 2010, Nature Biotechnology.

[15]  A. Gingras,et al.  Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1 , 2010, Nature.

[16]  Min Jae Lee,et al.  Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.

[17]  F. Colland The therapeutic potential of deubiquitinating enzyme inhibitors. , 2010, Biochemical Society transactions.

[18]  J. Boeke,et al.  Specificity of the BRISC Deubiquitinating Enzyme Is Not Due to Selective Binding to Lys63-linked Polyubiquitin* , 2009, The Journal of Biological Chemistry.

[19]  John Parkinson,et al.  Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays , 2009, Molecular systems biology.

[20]  Jun Qin,et al.  Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor α-induced Nuclear Factor κB Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1* , 2009, The Journal of Biological Chemistry.

[21]  D. Komander The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.

[22]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[23]  M. Moran,et al.  Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041* , 2009, Molecular & Cellular Proteomics.

[24]  Ying Zhang,et al.  DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors , 2009, Cell cycle.

[25]  Troels Z. Kristiansen,et al.  K63‐specific deubiquitination by two JAMM/MPN+ complexes: BRISC‐associated Brcc36 and proteasomal Poh1 , 2009, The EMBO journal.

[26]  E. Fiebiger,et al.  Structural basis and specificity of human otubain 1-mediated deubiquitination. , 2009, The Biochemical journal.

[27]  L. Luttrell,et al.  Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor. , 2009, Biochemistry.

[28]  Yili Yang,et al.  Targeting the ubiquitin‐proteasome system for cancer therapy , 2009, Cancer science.

[29]  Tatiana A. Tatusova,et al.  NCBI Reference Sequences: current status, policy and new initiatives , 2008, Nucleic Acids Res..

[30]  B. Kay,et al.  High-throughput biotinylation of proteins. , 2009, Methods in molecular biology.

[31]  B. Kessler,et al.  Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: Emerging patterns and molecular principles , 2008, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[32]  Robert Burke,et al.  ProteoWizard: open source software for rapid proteomics tools development , 2008, Bioinform..

[33]  A. Ciechanover,et al.  Itch: a HECT-type E3 ligase regulating immunity, skin and cancer , 2008, Cell Death and Differentiation.

[34]  W. Li,et al.  Polyubiquitin chains: functions, structures, and mechanisms , 2008, Cellular and Molecular Life Sciences.

[35]  M. Moran,et al.  Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. , 2008, Journal of proteome research.

[36]  F. Colland,et al.  Targeting ubiquitin specific proteases for drug discovery. , 2008, Biochimie.

[37]  S. Knapp,et al.  A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases , 2007, Proceedings of the National Academy of Sciences.

[38]  J. Wrana,et al.  Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 through Its C2 Domain , 2007, Cell.

[39]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[40]  K. Knobeloch,et al.  Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo , 2007, Molecular and Cellular Biology.

[41]  F. Mackenzie,et al.  Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8)* , 2006, Journal of Biological Chemistry.

[42]  J. Hurley,et al.  Ubiquitin-binding domains. , 2006, The Biochemical journal.

[43]  P. Febbo,et al.  The isopeptidase USP2a protects human prostate cancer from apoptosis. , 2006, Cancer research.

[44]  A. D'arcy,et al.  Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2 , 2006, Structure.

[45]  D. Allison,et al.  Increased Expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and Survivin is Associated with Poor Survival in Glioblastoma Multiforme (GBM) , 2006, Journal of Neuro-Oncology.

[46]  I. Prior,et al.  The Ubiquitin Isopeptidase UBPY Regulates Endosomal Ubiquitin Dynamics and Is Essential for Receptor Down-regulation* , 2006, Journal of Biological Chemistry.

[47]  Jay Painter,et al.  Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .

[48]  K. Inoki,et al.  TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase* , 2006, Journal of Biological Chemistry.

[49]  René Bernards,et al.  A Genomic and Functional Inventory of Deubiquitinating Enzymes , 2005, Cell.

[50]  Yigong Shi,et al.  Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14 , 2005, The EMBO journal.

[51]  S. Sidhu Phage display in biotechnology and drug discovery , 2005 .

[52]  K. Wilkinson,et al.  Derivitization of the C-terminus of ubiquitin and ubiquitin-like proteins using intein chemistry: methods and uses. , 2005, Methods in enzymology.

[53]  K. Nakayama,et al.  Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase , 2004, Nature Cell Biology.

[54]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[55]  C. Pickart,et al.  Ubiquitin: structures, functions, mechanisms. , 2004, Biochimica et biophysica acta.

[56]  David S. Wishart,et al.  SuperPose: a simple server for sophisticated structural superposition , 2004, Nucleic Acids Res..

[57]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[58]  B. Vogelstein,et al.  HAUSP is Required for p53 Destabilization , 2004, Cell cycle.

[59]  Muyang Li,et al.  A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.

[60]  Muyang Li,et al.  Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.

[61]  Wladek Minor,et al.  Automatic System for Crystallographic Data Collection and Analysis , 2002 .

[62]  S. Sidhu,et al.  Phage display for selection of novel binding peptides. , 2000, Methods in enzymology.

[63]  J. Merchant,et al.  ZBP-99 defines a conserved family of transcription factors and regulates ornithine decarboxylase gene expression. , 1999, Biochemical and biophysical research communications.

[64]  J. Ashby References and Notes , 1999 .

[65]  N. Copeland,et al.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice , 1998, Nature Genetics.

[66]  R. Stein,et al.  Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. , 1998, Biochemistry.

[67]  L. Presta,et al.  Mutational Analysis of Thrombopoietin for Identification of Receptor and Neutralizing Antibody Sites* , 1997, The Journal of Biological Chemistry.

[68]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[69]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[70]  T. Creighton Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.